CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 10,329 shares at $16.81 ($173,630)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 4,073 shares at $16.81 ($68,467)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 10,259 shares at $16.81 ($172,454)
- 4 Option exercise Director acquired 4,381 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 9,733 shares at $15.28 ($148,720)
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 9,534 shares at $15.28 ($145,680)
- 4 Open-market sale CEO sold 31,747 shares at $15.28 ($485,094)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 975 shares at $14.79 ($14,420)
- 4 Option exercise Director acquired 6,652 shares (option exercise)
- 4 Option exercise Director acquired 6,652 shares (option exercise)
- 4 Option exercise Director acquired 6,652 shares (option exercise)
- 4 Option exercise Director acquired 6,652 shares (option exercise)
- 4 Option exercise Director acquired 6,652 shares (option exercise)
- 4 Option exercise Director acquired 6,652 shares (option exercise)
- 4 Grant or award Director acquired 37,548 shares (grant or award)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,503 shares at $16.94 ($59,341)
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 3,477 shares at $16.94 ($58,900)
Page 4 of 35 · 686 filings